Back to Search
ALEXANDER PADILLA, PHARMD
PHARMD
Pharmacist
NPI: 1699658922Individual
Specialties, Licenses & Credentials
Critical Care Pharmacist
Pharmacist — Critical Care
Code: 1835C0205X
90260(CA)
Emergency Medicine Pharmacist
Pharmacist — Emergency Medicine
Code: 1835E0208X
90260(CA)
Infectious Diseases Pharmacist
Pharmacist — Infectious Diseases
Code: 1835I0206X
90260(CA)
PharmacistPrimary
Pharmacist
Code: 183500000X
90260(CA)
Research & Publications (20)
Insufficient TLR activation contributes to the slow development of CD8+ T cell responses in Trypanosoma cruzi infection.
PMID 19553540·J Immunol·2009
7-preclinical
[Validity and reliability of the St George's Respiratory Questionnaire in adults with cystic fibrosis].
PMID 17397584·Arch Bronconeumol·2007
4-observational
Limited role for CD4+ T-cell help in the initial priming of Trypanosoma cruzi-specific CD8+ T cells.
PMID 17043105·Infect Immun·2007
7-preclinical
Canine infection and the possible role of dogs in the transmission of American tegumentary leishmaniosis in Salta, Argentina.
PMID 12446084·Vet Parasitol·2002
7-preclinical
Kinetics and characterization of cellular responses in the peritoneal cavity of mice infected with Taenia crassiceps.
PMID 11426723·J Parasitol·2001
7-preclinical
Predictors of adverse events after percutaneous transluminal coronary angioplasty in a group of Hispanic patients.
PMID 11394217·P R Health Sci J·2001
8-other
Second-generation highly potent and selective inhibitors of the hepatitis C virus NS3 serine protease.
PMID 19196021·J Med Chem·2009
7-preclinical
In vitro antimicrobial effect of bacteriocin PsVP-10 in combination with chlorhexidine and triclosan against Streptococcus mutans and Streptococcus sobrinus strains.
PMID 19124118·Arch Oral Biol·2009
8-other
Removing the invariant salt bridge of parvalbumin increases flexibility in the AB-loop structure.
PMID 19622856·Acta Crystallogr D Biol Crystallogr·2009
7-preclinical
Toward second generation hepatitis C virus NS3 serine protease inhibitors: discovery of novel P4 modified analogues with improved potency and pharmacokinetic profile.
PMID 19371095·J Med Chem·2009
7-preclinical
Discovery of novel P3 sulfonamide-capped inhibitors of HCV NS3 protease. Inhibitors with improved cellular potencies.
PMID 19481946·Bioorg Med Chem·2009
7-preclinical
NMR structure of rALF-Pm3, an anti-lipopolysaccharide factor from shrimp: model of the possible lipid A-binding site.
PMID 19107926·Biopolymers·2009
7-preclinical
Lead exposures in U.S. Children, 2008: implications for prevention.
PMID 18941567·Environ Health Perspect·2008
8-other
Intrinsic viscosity of bovine serum albumin conformers.
PMID 18022223·Int J Biol Macromol·2008
7-preclinical
Social cognition, ethnic identity, and ethnic specific strategies for coping with threat due to prejudice and discrimination.
PMID 18232129·Nebr Symp Motiv·2008
8-other
Hepatitis C virus NS3-4A serine protease inhibitors: SAR of new P1 derivatives of SCH 503034.
PMID 18547808·Bioorg Med Chem Lett·2008
8-other
Frightened in isolation: unique considerations for research of sexual assault and interpersonal violence in rural areas.
PMID 17479565·J Forensic Nurs·2007
6-review
Structure-based discovery of an inhibitor of Arf activation by Sec7 domains through targeting of protein-protein complexes.
PMID 17563369·Proc Natl Acad Sci U S A·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 16759 CHERRY TREE LN
FONTANA, CA 92336 - Phone
- (909) 279-4380
Quick Facts
- NPI
- 1699658922
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 4
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile